PC12 is a rat pheochromocytoma cell line established in 1976 by Greene and Tischler. This immortalized cell line derived from the adrenal medulla has become one of the most widely used models in neuroscience research for studying neuronal differentiation, neurotoxicity, and Parkinson's disease mechanisms.
| Property |
Value |
| Species |
Rat (Rattus norvegicus) |
| Tissue Origin |
Adrenal medulla (pheochromocytoma) |
| Cell Type |
Chromaffin cells / Neuron-like cells |
| Key Marker Genes |
TH (tyrosine hydroxylase), PHOX2B, DBH, DAT (SLC6A3), VMAT2 (SLC18A2) |
| Differentiation |
NGF induces neurite outgrowth and neuronal phenotype |
| Applications |
Neuronal differentiation, neurotoxicity, PD research, drug screening |
In their undifferentiated state, PC12 cells:
- Exhibit chromaffin-like phenotype
- Express catecholamine biosynthesis enzymes (TH, DBH)
- Contain dense-core vesicles with catecholamines
- Possess some neuronal properties but do not fire action potentials
- Divide every 2-3 days in culture
Upon treatment with nerve growth factor (NGF):
- Phase 1 (Days 1-7): Initial neurite outgrowth begins
- Phase 2 (Days 7-14): Extensive neurite extension and branching
- Phase 3 (Day 14+): Fully differentiated neuron-like cells
Key changes during differentiation:
- Cessation of cell division
- Extension of neurites (axons and dendrites)
- Expression of neuronal markers (neurofilaments, MAP2)
- Development of voltage-gated ion channels
- Increased catecholamine synthesis
- Formation of synaptic-like vesicles
graph TD
A["NGF"] --> B["TrkA Receptor"]
B --> C["Ras/MAPK Pathway"]
B --> D["PI3K/Akt Pathway"]
B --> E["PLCγ Pathway"]
C --> F["Cell Differentiation"]
D --> G["Survival"]
E --> H["Calcium Signaling"]
F --> I["Neurite Outgrowth"]
G --> I
H --> I
Critical pathways include:
- TrkA receptor activation: High-affinity NGF receptor
- MAPK/ERK pathway: Mediates differentiation
- PI3K/Akt pathway: Promotes survival
- PLCγ signaling: Calcium mobilization
PC12 cells are extensively used in PD research:
-
Alpha-Synuclein Toxicity
- Transfection with α-synuclein to model Lewy body formation
- Studies on oxidative stress-induced aggregation
- Drug screening for aggregation inhibitors
-
Neurotoxin Models
- MPP+ (MPTP metabolite) treatment
- 6-OHDA exposure
- Rotenone application
- All induce dopaminergic-like cell death
-
Mitochondrial Dysfunction
- Complex I inhibition studies
- ROS generation mechanisms](/entities)
- Neuroprotective Drug Screening
- Testing compounds for dopaminergic protection
- Antioxidant screening
- Autophagy modulators
PC12 cells serve as a model for:
- Metal toxicity: Manganese, iron, copper
- Environmental toxins: Pesticides, industrial chemicals
- Drug-induced neuropathy: Chemotherapy agents
- Amyloid-beta toxicity: Relevance to Alzheimer's disease
| Feature |
PC12 |
SH-SY5Y |
Primary Neurons |
| Species |
Rat |
Human |
Various |
| Tumor-derived |
Yes |
Yes |
No |
| Differentiates |
Yes (NGF) |
Yes (RA) |
N/A |
| Dopaminergic |
Yes (partial) |
Yes |
Yes |
| Cost |
Low |
Low |
High |
| Genetic manipulation |
Easy |
Easy |
Difficult |
| Physiological relevance |
Moderate |
Moderate |
High |
¶ Maintenance (Undifferentiated)
- Culture medium: RPMI 1640 + 10% horse serum + 5% FBS
- Incubator: 37°C, 5% CO2
- Passaging: 70-80% confluency
- No NGF added
- Seed cells on poly-L-lysine coated plates
- Replace with differentiation medium (RPMI + 1% horse serum)
- Add NGF (50-100 ng/mL)
- Refresh NGF every 2-3 days
- Complete differentiation: 10-14 days
- Differentiate cells for 10-14 days
- Treat with toxin (e.g., 1-5 mM MPP+)
- Assess viability at 24-72 hours
- Measure: MTT reduction, ATP levels, ROS, apoptosis markers
- Tumor origin: May not fully recapitulate primary neurons
- Species difference: Rat cells, not human
- Incomplete differentiation: Never fully mature neurons
- Clonal variation: Different PC12 sublines vary
- Catecholamine phenotype: Adrenal rather than midbrain origin
- Greene & Tischler, Establishment of a clonal line of rat adrenal pheochromocytoma cells (1976)
- Tischler et al., Protein kinase C activation and muscarinic receptor function (1990)
- Le et al., Alpha-synuclein aggregation in PC12 cells (2001)
- Jiang et al., Mitochondrial dysfunction in PC12 cells exposed to rotenone (2010)